Clinical Trials Sponsored by Bill & Melinda Gates Foundation Visitor Center

Total 412 results

PATH
Bill and Melinda Gates Foundation

Completed

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

Virus Diseases | Hepatitis B
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous

Peru
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

Brazil
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
Novavax
Bill and Melinda Gates Foundation

Completed

A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

COVID-19 | SARS-CoV-2 Infection

South Africa
Jhpiego
Bill and Melinda Gates Foundation

Completed

Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach

Stillbirth | Neonatal Death
IDRI
Bill and Melinda Gates Foundation

Completed

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
Jhpiego
Bill and Melinda Gates Foundation

Completed

Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa

Infant Death | Maternal Death | Stillbirth

Congo, The Democratic Republic of the
Novavax
Bill and Melinda Gates Foundation

Completed

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Respiratory Syncytial Virus Infections

United States, Argentina, Australia, Bangladesh, Chile, Mexico, New Zealand, Philippines, South Africa, Spain, United Kingdom
IDRI
Bill and Melinda Gates Foundation

Completed

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Visceral Leishmaniasis

United States
IDRI
Bill and Melinda Gates Foundation

Completed

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Visceral Leishmaniasis | Post-kala-azar Dermal Leishmaniasis

India
PATH
Bill and Melinda Gates Foundation

Withdrawn

Efficacy of iOWH032 in Dehydrating Cholera (POC)

Secretory Diarrhea

Bangladesh
Bill & Melinda Gates Medical Research Institute
Bill and Melinda Gates Foundation; Wellcome Trust

Recruiting

Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

Tuberculosis

Indonesia, Kenya, Malawi, Mozambique, South Africa, Vietnam, Zambia
PATH
Bill and Melinda Gates Foundation; UNITAID

Recruiting

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

Focus of Study: Accurate Clinical Measurement and Diagnosis

Kenya
Tufts University
Bill and Melinda Gates Foundation

Recruiting

Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers

Iron

United States
Yale University
Bill and Melinda Gates Foundation

Completed

Topical Antibacterial Agents for Prevention of COVID-19

COVID-19 | SARS-CoV2 Infection

United States
Stanford University
Bill and Melinda Gates Foundation

Completed

Use of Mobile Technology by Community-Based Health Workers to Promote Maternal and Child Health in Bihar, India (ICT-CCS)

Child | Pregnancy | Infant | Nutrition | Health
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants

Poliomyelitis

Dominican Republic
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children (M2-ABMG)

Adverse Event Following Immunisation
VaxInnate Corporation
Bill and Melinda Gates Foundation

Completed

Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults

Influenza Infection

United States
Makerere University
Bill and Melinda Gates Foundation

Completed

School Based Malaria Control in Ugandan Schoolchildren (SBMC)

Malaria

Uganda
Population Council
Bill and Melinda Gates Foundation

Recruiting

Pilot Study on Engaging Family Physicians in Family Planning in Pakistan (FPFP)

Contraception | Contraceptive Usage

Pakistan
FHI 360
Bill and Melinda Gates Foundation

Recruiting

Casea S Contraceptive Implants (Casea S) Trial

Contraception

Dominican Republic
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Poliomyelitis

Dominican Republic, Panama
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age (T2-ABMG)

Poliomyelitis
Fidec Corporation
Bill and Melinda Gates Foundation

Withdrawn

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Poliomyelitis
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania (M3-ABMG)

Poliomyelitis
FHI 360
Bill and Melinda Gates Foundation

Completed

Safety,Effectiveness and Acceptability of Sino-implant II in DR

Contraception

Dominican Republic
Boston University
Bill and Melinda Gates Foundation

Completed

Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia

Pneumonia, Bacterial | Infections, Bacterial

Malawi
Vaxtrials S.A.
Bill and Melinda Gates Foundation

Completed

Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life (IPV005)

Polio

Panama
Artann Laboratories
Bill and Melinda Gates Foundation

Completed

Clinical Evaluation of Ultrasonic Hydration Monitor for Infants (IHM-01)

Diarrhea | Dehydration

Latvia
Fidec Corporation
Bill and Melinda Gates Foundation

Active, not recruiting

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2

Poliomyelitis

Bangladesh
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

Poliomyelitis

Panama
Stanford University
Bill and Melinda Gates Foundation

Completed

Team-Based Goals and Incentives for Community-Based Health Workers to Promote Maternal and Child Health in Bihar, India

Healthy
Certara
Bill and Melinda Gates Foundation; Parexel

Completed

International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global) (UNITY Global)

Covid19 | SARS-CoV Infection

Pakistan
Makerere University
Bill and Melinda Gates Foundation

Active, not recruiting

Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage

Polio

Uganda
Fidec Corporation
Bill and Melinda Gates Foundation

Withdrawn

A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine

Poliomyelitis
FHI 360
Bill and Melinda Gates Foundation

Completed

Contraceptive Effectiveness of Sino-implant (II) in China

Contraception

China
Radboud University Medical Center
Bill and Melinda Gates Foundation

Completed

Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection (BMGF2b)

Malaria

Netherlands
Radboud University Medical Center
Bill and Melinda Gates Foundation

Completed

Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis (BMGF1)

Malaria

Netherlands
University of North Carolina, Chapel Hill
Bill and Melinda Gates Foundation

Completed

Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age

Pregnancy Related | Machine Learning | Gestational Age

United States, Zambia
University of North Carolina, Chapel Hill
Bill and Melinda Gates Foundation

Completed

Limiting Adverse Birth Outcomes in Resource-Limited Settings (LABOR)

Respiratory Infection | Labor and Delivery | Birth Outcomes

Ghana, India, Zambia
Ataulpho de Paiva Foundation
Bill and Melinda Gates Foundation

Completed

Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil

Tuberculosis

Brazil
National Cancer Institute (NCI)
Bill and Melinda Gates Foundation

Enrolling by invitation

Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study (ESCUDDO)

Human Papillomavirus Infection | Human Papillomavirus-Related Cervical Carcinoma

Costa Rica
Massachusetts General Hospital
Bill and Melinda Gates Foundation

Recruiting

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study

HIV | Human Immunodeficiency Virus | ART

South Africa
Aga Khan University
Bill and Melinda Gates Foundation

Completed

Implementation at Scale and Evaluation of KMC (KMC)

Newborn Morbidity

Pakistan
Vir Biotechnology, Inc.
Bill and Melinda Gates Foundation

Completed

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

HIV I Infection

United States
University of Washington
Bill and Melinda Gates Foundation

Terminated

Treatment for COVID-19 in High-Risk Adult Outpatients

COVID-19 | SARS-CoV-2

United States
University of Minnesota
Bill and Melinda Gates Foundation

Completed

Losartan for Patients With COVID-19 Requiring Hospitalization

Acute Respiratory Distress Syndrome | Corona Virus Infection | SARS-CoV Infection

United States
Aga Khan University
Bill and Melinda Gates Foundation

Completed

Community Mobilization and Incentivization for Childhood Diarrhea and Pneumonia (CoMIC)

Childhood Diarrhea | Childhood Pneumonia | Community Mobilisation | Sanitation and Hygiene | Community Incentives

Pakistan

Clinical Trials Sponsored by Bill & Melinda Gates Foundation Visitor Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations